AdCare Health Systems said it has priced an offering of approximately 1.71 million shares of common stock at $3.50 per share, below Tuesday's closing price of $3.72. Underwriters were granted a 30-day option to purchase up to an additional 257,143 shares to cover overallotments.
Net proceeds of approximately $5.5 million will be used for acquisition purposes, working capital and general corporate purposes, AdCare Health said.
Shares of AdCare Health were down 23 cents, or 6.2%, to $3.49, below the offering price. The stock is now down more than 11% in 2010, although it has gained more than 55% over the last 12 months.Elsewhere, MELA Sciences (MELA) priced a public offering of 2.2 million shares of common stock at $7.50 per share. Underwriters have a 30-day option to acquire an additional 330,000 shares to cover overallotments, if any. MELA Sciences said it expects net proceeds of approximately $17.5 million, assuming exercise of the overallotment option. TheStreet's Adam Feuerstein reports that MELA Sciences CEO Joseph Gulfo said during a Tuesday night conference call that the decision to sell stock now was made to "reduce headwinds and market uncertainty" surrounding the company's existing cash position. Shares of MELA Sciences were sliding by 73 cents, or 8.8%, to $7.57. StemCells (STEM) shares also traded lower after the company announced a $6 million equity financing deal. StemCells agreed to sell 7 million shares of its common stock to private-investment partnership Seaside 88 at a price of 86.5 cents per share, a 12.6% discount to Tuesday's closing price. StemCells expects to receive net proceeds from of approximately $5.7 million. Seaside 88 has agreed to purchase an additional 5 million shares of common stock 12 weeks after the initial closing, although StemCells may elect not to sell the additional shares. Still, shares of the company were down 3.5% to 95.5 cents during Wednesday's trading session. Energy, Inc. (EGAS) said late Tuesday it has filed for public offering of up to 2.5 millions shares of common stock. The company said it will sell up to 1.5 million shares of common stock selling shareholders may offer up to 1 million shares. Underwriters also have a 30-day option to purchase up to an additional 375,000 shares to cover overallotments, if any.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV